Pharmacogenomic testing in children: practicalities and implications
A pharmacogenomic testing service involves more than simply reporting that a patient has a genetic variant that affects the way they respond to a drug. In a session… read more.
A pharmacogenomic testing service involves more than simply reporting that a patient has a genetic variant that affects the way they respond to a drug. In a session… read more.
Smoking has long been associated with Erectile Dysfunction (ED) and Cardiovascular Disease (CVD). However, little research has explored whether there is a similar association among men who use… read more.
An essential part of obesity care is making sure treatments are safe for patients. Abdulrahman Alsuhibani, a doctoral student in the University of Cincinnati’s James L. Winkle College… read more.
The European Medicines Agency (EMA) has published new guidance on generating evidence from patient registries. The publication aims to increase the quality of research using the wealth of… read more.
Medicines approved by the European Medicines Agency (EMA) to treat one illness could be repurposed by academics and non-governmental organisations as therapies for other illnesses, as part of… read more.
A total of 67 new medicines have been approved by the European Medicines Agency (EMA) in 2021. This includes six new products backed by the watchdog’s key advisory… read more.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that biologics were the most common initial treatment prescribed to treat systemic… read more.
A robust business case can be made for the VTE service and the coronavirus pandemic has further demonstrated the value of the service, according to Mr Kieron Power;… read more.
Ministers are announcing action to prevent medicines being prescribed unnecessarily, following a new review led by Dr Keith Ridge CBE, Chief Pharmaceutical Officer for England. The review of… read more.
Patient pathways, independent prescribing by pharmacists and education of junior doctors all contribute to the effective operation of the VTE service, according to Mr Kieron Power; Lead Pharmacist… read more.
Recurrence of venous thrombo-embolism (VTE) may be more common than people think and 30% of people develop post thrombotic syndrome, according to Mr Kieron Power; Lead Pharmacist –… read more.
Specialist pharmacists are now the primary clinicians who look after patients with venous thromboembolism (VTE) at Singleton Hospital in Swansea. IMI spoke to Mr Kieron Power, Clinical Lead… read more.
Advertisment